Original Research
Published on 21 Dec 2021
Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
in Renal Pharmacology
- 6,560 views
- 14 citations
Original Research
Published on 21 Dec 2021
in Renal Pharmacology
Review
Published on 26 Feb 2013
in Clinical Diabetes
Original Research
Published on 30 Nov 2020
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 24 May 2019
in Drugs Outcomes Research and Policies
Original Research
Published on 22 Dec 2021
in Clinical Diabetes
Mini Review
Published on 08 May 2019
in Stroke
Original Research
Published on 14 Oct 2022
in Family Medicine and Primary Care
Original Research
Published on 03 Mar 2020
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 12 Apr 2018
in Immunological Tolerance and Regulation
Original Research
Published on 19 Jul 2022
in Bone Research
Case Report
Published on 28 Feb 2022
in Clinical Diabetes
Original Research
Published on 18 Dec 2018
in Inflammation
Original Research
Published on 12 Jan 2026
in Renal Pharmacology
Original Research
Published on 04 Oct 2022
in Clinical Diabetes
Original Research
Published on 23 May 2023
in Asthma
Original Research
Published on 26 Nov 2020
in Renal Pharmacology